Impact of anti-peptic ulcer disease medications on type 2 diabetes mellitus risk in patients with PUD: a population-based retrospective cohort study

• Published in: Therapeutic advances in endocrinology and metabolism Vol. 16; p. 20420188251323945
• Main Authors: Fang, Yi-Jen, Hsieh, Hui-Hsia, Lin, Cheng-Li, Lee, Wan-Yi, Chen, Chi-Hua, Tsai, Fuu-Jen, You, Bang-Jau, Tien, Ni, Lim, Yun-Ping
• Format: Journal Article
• Language: English
• Published: United States SAGE Publications 01.01.2025; SAGE Publishing
• Subjects: Original Research; retrospective cohort study; anti-PUD medications; peptic ulcer disease (PUD); type 2 diabetes mellitus (T2DM)

The etiology of type 2 diabetes mellitus (T2DM) is complex, with environmental factors playing a significant role in its pathophysiology. Nonsteroidal anti-inflammatory drugs usage and infection are the two most frequent causes of peptic ulcer disease (PUD). The link between PUD and T2DM is unclear,...